Long-term cost-effectiveness of disease management in systolic heart failure

Medical Decision Making

Volumn 29, Issue 3, 2009, Pages 325-333

  Miller, George ^a   Randolph, Stephen ^b   Forkner, Emma ^b   Smith, Brad ^b   Galbreath, Autumn Dawn ^b  

^a ALTARUM INSTITUTE   (United States)

^b NONE

Author keywords

Congestive heart failure; Cost effectiveness; Markov model; Patients; Systolic

Indexed keywords

AGING; ARTICLE; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; DEMOGRAPHY; DISEASE SEVERITY; HEALTH CARE COST; LIFE EXTENSION; MORTALITY; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS; SYSTOLIC HEART FAILURE; AGED; CLINICAL TRIAL; COST BENEFIT ANALYSIS; DISEASE MANAGEMENT; ECONOMICS; FEMALE; HUMAN; MALE; MIDDLE AGED; VALIDATION STUDY;

AGED; CLINICAL TRIALS AS TOPIC; COST-BENEFIT ANALYSIS; DISEASE MANAGEMENT; FEMALE; HEART FAILURE, SYSTOLIC; HUMANS; MALE; MIDDLE AGED; QUALITY-ADJUSTED LIFE YEARS;

EID: 67649171240     PISSN: 0272989X     EISSN: 1552681X     Source Type: Journal    
DOI: 10.1177/0272989X08327494     Document Type: Article

References (30)

1. Capomolla S., Febo O., Ceresa M., et al. Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care. J Am Coll Cardiol. 2002 ; 40 (7). 1259-66.
2. Hershberger RE, Nauman DJ, Byrkit J., et al. Prospective evaluation of an outpatient heart failure disease management program designed for primary care: the Oregon model. J Card Fail. 2005 ; 11 (4). 293-8.
3. Laramee AS, Levinsky SK, Sargent J., Ross R., Callas P. Case management in a heterogeneous congestive heart failure population: a randomized controlled trial. Arch Intern Med. 2003 ; 163 (7). 809-17.
4. Mejhert M., Kahan T., Persson H., Edner M. Limited long term effects of a management programme for heart failure. Heart. 2004 ; 90 (9). 1010-5.
5. DeBusk RF, Miller NH, Parker KM, et al. Care management for low-risk patients with heart failure: a randomized, controlled trial. Ann Intern Med. 2004 ; 141 (8). 606-13.
6. Riegel B, Carlson B, Kopp Z, LePetri B, Glaser D, Unger A. Effect of a standardized nurse case-management telephone intervention on resource use in patients with chronic heart failure. Arch Intern Med. 2002 ; 162 (6). 705-12.
7. Nucifora G., Albanese M., De Biaggio P., Caliandro D., Gregori D., Goss P. Lack of improvement of clinical outcomes by a low-cost, hospital-based heart failure management programme. J Cardiovasc Med. 2006 ; 7 (8). 614-22.
8. Dunagan WC, Littenberg B., Ewald GA, Jones CA, Emery VB, Waterman BM Randomized trial of a nurse-administered, telephone-based disease management program for patients with heart failure. J Card Fail. 2005 ; 11 (5). 358-65.
9. Gesica Investigators. Randomised trial of telephone intervention in chronic heart failure: Dial trial. BMJ. 2005 ; 331 (7514). 425-30.
10. Kimmelstiel C., Levine D., Perry K., et al. Randomized, controlled evaluation of short- and long-term benefits of heart failure disease management within a diverse provider network: the SPAN-CHF trial. Circulation. 2004 ; 110 (11). 1450-5.
11. Kasper EK, Gerstenblith G., Hefter G., et al. A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission. J Am Coll Cardiol. 2002 ; 39 (3). 471-80.
12. Krumholz H., Amatruda J., Smith G., Mattera J., Roumanis S., Radford M. Randomized trial of an education and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol. 2002 ; 39 (1). 83-9.
13. McAlister FA, Stewart S., Ferrua S., McMurray JJ Multidisciplinary strategies for the management of heart failure patients at high risk for admission: a systematic review of randomized trials. J Am Coll Cardiol. 2004 ; 44 (4). 810-9.
14. Smith B., Hughes-Cromwick P., Forkner E., Galbreath AD Cost-effectiveness of telephonic disease management in heart failure. Am J Manag Care. 2008 ; 14 (2). 106-15.
15. Galbreath AD, Krasuski RA, Smith B., et al. Long-term healthcare and cost outcomes of disease management in a large, randomized, community-based population with heart failure. Circulation. 2004 ; 110 (23). 3518-26.
16. Smith B., Forkner E., Zaslow B., et al. Disease management produces limited quality-of-life improvements in patients with congestive heart failure: evidence from a randomized trial in community-dwelling patients. Am J Manag Care. 2005 ; 11 (11). 701-13.
17. Gold M., Russell L., Siegel J., Weinstein M. Cost-Effectiveness in Health and Medicine. New York: Oxford University Press ; 1996. 18. Briggs A., Sculpher M. An introduction to Markov modelling for economic evaluation. Pharmacoeconomics. 1998 ; 13 (4). 397-409.
18. Sonnenberg FA, Beck JR Markov models in medical decision making: a practical guide. Med Decis Making. 1993 ; 13 (4). 322-38.
19. Crouter A., Forkner E., Miller G., Randolph S., Waisanen L. Healthcare Management Model (HMM) Version 2.0. Ann Arbor (MI): Altarum Institute ; 2002.
20. Arias E. United States life tables, 2002. Natl Vital Stat Report. 2004 ; 53 ( 6 ).
21. Levy WC, Mozaffarian D., Linker DT, et al. The Seattle heart failure model: prediction of survival in heart failure. Circulation. 2006 ; 113 (11). 1424-33.
22. Thomson, ed. 2003 Drug Topics Red Book. Montvale (NJ): Thomson PDR ; 2003.
23. Mosby, ed. Mosby's Drug Consult 2003. St. Louis: Mosby Publications ; 2003.
24. Brazier J., Roberts J., Deverill M. The estimation of a preference-based measure of health from the SF-36. J Health Econ. 2002 ; 21 (2). 271-92.
25. Data from the 1996 Medical Expenditure Panel Survey (MEPS) Projected to 2003-2008: Medical Expenditures by Type of Service and Source of Payment for Age, Race and Sex. Data file documentation. Rockville (MD): Center for Financing, Access and Cost Trends, Agency for Healthcare Research and Quality ; 2004.
26. Morimoto T., Hayashino Y., Shimbo T., Izumi T., Fukui T. Is B-type natriuretic peptide-guided heart failure management cost-effective? Int J Cardiol. 2004 ; 96 (2). 177-81.
27. Sanders G., Hlatky M., Owens D. Cost-effectiveness of implantable cardioverter-defibrillators. N Engl J Med. 2005 ; 353 (14). 1471-80.
28. Evans C., Tavakoli M., Crawford B. Use of quality adjusted life years and life years gained as benchmarks in economic evaluations: a critical appraisal. Health Care Manag Sci. 2004 ; V7 (1). 43-9.
29. Ubel PA, Hirth RA, Chernew ME, Fendrick AM What is the price of life and why doesn't it increase at the rate of inflation ? Arch Intern Med. 2003 ; 163 (14). 1637-41.
30. Chan DC, Heidenreich PA, Weinstein MC, Fonarow GC Heart failure disease management programs: a cost-effectiveness analysis. Am Heart J. 2008 ; 155 (2). 333-8.